CA2548375A1 - Evaluation du risque de cancer colono-rectal - Google Patents

Evaluation du risque de cancer colono-rectal Download PDF

Info

Publication number
CA2548375A1
CA2548375A1 CA 2548375 CA2548375A CA2548375A1 CA 2548375 A1 CA2548375 A1 CA 2548375A1 CA 2548375 CA2548375 CA 2548375 CA 2548375 A CA2548375 A CA 2548375A CA 2548375 A1 CA2548375 A1 CA 2548375A1
Authority
CA
Canada
Prior art keywords
base
human chromosome
increased risk
linkage therewith
disequilibrium linkage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2548375
Other languages
English (en)
Inventor
Michelle Cotterchio
Steven Gallinger
Celia Greenwood
Thomas J. Hudson
Brent W. Zanke
Michael Phillips
Saravanan Sundararajian
Alexandre Montpetit
Phillippe Laflamme
Vincent Ferretti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Cancer Care Ontario
Original Assignee
McGill University
Cancer Care Ontario
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McGill University, Cancer Care Ontario filed Critical McGill University
Priority to CA 2548375 priority Critical patent/CA2548375A1/fr
Priority to PCT/CA2007/000993 priority patent/WO2007140599A1/fr
Priority to US12/303,410 priority patent/US8153369B2/en
Priority to CA002654165A priority patent/CA2654165A1/fr
Priority to EP10007610A priority patent/EP2236623A1/fr
Priority to AU2007257162A priority patent/AU2007257162A1/en
Priority to EP07719909A priority patent/EP2035439A4/fr
Publication of CA2548375A1 publication Critical patent/CA2548375A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA 2548375 2006-06-05 2006-06-13 Evaluation du risque de cancer colono-rectal Abandoned CA2548375A1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CA 2548375 CA2548375A1 (fr) 2006-06-13 2006-06-13 Evaluation du risque de cancer colono-rectal
PCT/CA2007/000993 WO2007140599A1 (fr) 2006-06-05 2007-06-05 Évaluation de risque pour cancer colorectal
US12/303,410 US8153369B2 (en) 2006-06-05 2007-06-05 Assessment of risk for colorectal cancer
CA002654165A CA2654165A1 (fr) 2006-06-05 2007-06-05 Evaluation de risque pour cancer colorectal
EP10007610A EP2236623A1 (fr) 2006-06-05 2007-06-05 Evaluation du risque dans le cancer colorectal
AU2007257162A AU2007257162A1 (en) 2006-06-05 2007-06-05 Assessment of risk for colorectal cancer
EP07719909A EP2035439A4 (fr) 2006-06-05 2007-06-05 Évaluation de risque pour cancer colorectal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2548375 CA2548375A1 (fr) 2006-06-13 2006-06-13 Evaluation du risque de cancer colono-rectal

Publications (1)

Publication Number Publication Date
CA2548375A1 true CA2548375A1 (fr) 2007-12-13

Family

ID=38829276

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2548375 Abandoned CA2548375A1 (fr) 2006-06-05 2006-06-13 Evaluation du risque de cancer colono-rectal

Country Status (1)

Country Link
CA (1) CA2548375A1 (fr)

Similar Documents

Publication Publication Date Title
US20110189663A1 (en) Assessment of risk for colorectal cancer
US20090317816A1 (en) Methods for identifying risk of breast cancer and treatments thereof
US8153369B2 (en) Assessment of risk for colorectal cancer
US8114592B2 (en) Genetic markers associated with age-related macular degeneration, methods of detection and uses thereof
CA2561742A1 (fr) Procedes d'identification de risque d'osteoarthrite et traitements associes
US20050064440A1 (en) Methods for identifying risk of melanoma and treatments thereof
US20050277118A1 (en) Methods for identifying subjects at risk of melanoma and treatments thereof
CA2547824A1 (fr) Evaluation des risques de cancer colono-rectal
US20050064442A1 (en) Methods for identifying risk of breast cancer and treatments thereof
CA2548375A1 (fr) Evaluation du risque de cancer colono-rectal
CA2579588A1 (fr) Evaluation du risque de cancer colono-rectal
WO2009050507A1 (fr) Marqueurs pour le cancer colorectal
CA2567973A1 (fr) Procedes pour identifier un risque de cancer du sein et traitements associes
US20050118606A1 (en) Methods for identifying risk of breast cancer and treatments thereof
EP2112229A2 (fr) Procédés d'identification du risque du cancer du sein et traitements associés

Legal Events

Date Code Title Description
FZDE Dead